pmKate2-paxillin

pmKate2-paxillin vector

cat.# FP323

The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced.


Download
vector information:
ProductCat.#SizePrice
pmKate2-paxillinFP32320 μg€ 400
The price does not include delivery. The price varies in different countries. Please contact your local distributor for exact prices and delivery information.

Vector typemammalian expression vector
ReportermKate2
Reporter codon usagemammalian
Promoter for mKate2PCMV IE
Host cellsmammalian
Selectionprokaryotic – kanamycin
eukaryotic – neomycin (G418)
Replicationprokaryotic – pUC ori
eukaryotic – SV40 ori
Use far-red fluorescent labeling of paxillin

Location of features

PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
Paxillin-mKate2 fusion: 600-3038
Paxillin: 600-2276
Start codon (ATG): 600-602
Last amino acid in Paxillin: 2274-2276
mKate2: 2343-3038
Stop codon: 3039-3041
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 3194-3199 & 3223-3228
mRNA 3' ends: 3232 & 3244
f1 single-strand DNA origin: 3291-3746
Bacterial promoter for expression of Kanr gene
-35 region: 3808-3813
-10 region: 3831-3836
Transcription start point: 3843
SV40 origin of replication: 4087-4222
SV40 early promoter
Enhancer (72-bp tandem repeats): 3920-3991 & 3992-4063
21-bp repeats: 4067-4087, 4088-4108 & 4110-4130
Early promoter element: 4143-4149
Major transcription start points: 4139, 4177, 4183 & 4188
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 4271-4273
Stop codon: 5063-5065
G->A mutation to remove Pst I site: 4453
C->A (Arg to Ser) mutation to remove BssH II site: 4799
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 5301-5306 & 5314-5319
pUC plasmid replication origin: 5650-6293


Notice to Purchaser:

Evrogen Fluorescent Protein Products (the Products) are intended for research use only. The Products are covered by Evrogen Patents and/or Patent applications pending. By use of these Products, you accept the terms and conditions of the applicable Limited Use Label License.

The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.

Copyright 2002-2011 Evrogen. All rights reserved.
Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, Tel +7(495)988-4084, Fax +7(495)988-4085, e-mail:evrogen@evrogen.com